Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 953-964

  Zhu, Xiao Ming ^a   Wang, Yi Xiang J ^a   Leung, Ken Cham Fai ^b,c   Lee, Siu Fung ^b   Zhao, Feng ^a   Wang, Da Wei ^b   Lai, Josie M Y ^b   Wan, Chao ^b   Cheng, Christopher H K ^b   Ahuja, Anil T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Cellular uptake; Iron oxide; Magnetic nanoparticles; SPIO; Surface coating

Indexed keywords

AMINOSILANE; DEXTRAN; SILANE; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; AMINO PROPYL TRIETHOXYSILANE; AMINO-PROPYL-TRIETHOXYSILANE; DRUG CARRIER; FERRIC FERROCYANIDE; FERRIC ION; FERRIC OXIDE; FERROCYANIDE; MAGNETITE NANOPARTICLE; SILANE DERIVATIVE; TETRAETHOXYSILANE;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL LABELING; CELL TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; MAMMAL CELL; MATERIAL COATING; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOUSE; NANOFABRICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ANALYSIS OF VARIANCE; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOCHEMISTRY; DRUG EFFECT; INTRACELLULAR SPACE; TUMOR CELL LINE;

MAMMALIA; SPIO;

ANALYSIS OF VARIANCE; ANIMALS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; FERRIC COMPOUNDS; FERROCYANIDES; HISTOCYTOCHEMISTRY; HUMANS; INTRACELLULAR SPACE; MAGNETITE NANOPARTICLES; MICE; SILANES; SURFACE PROPERTIES;

EID: 84860343951     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28316     Document Type: Article

References (51)

1. Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol. 2011;165(7-8):1628-1651.
2. Meng H, Xue M, Xia T, et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano. 2011;5(5):4131-4144.
3. Morton JG, Day ES, Halas NJ, West JL. Nanoshells for photothermal cancer therapy. Methods Mol Biol. 2010;624:101-117.
4. Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther. 2006;317(3): 1372-1381.
5. Garber K. Improved paclitaxel formulation hints at new chemotherapy approach. J Natl Cancer Inst. 2004;96(2):90-91.
6. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11(11):2319-2331.
7. Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006;58(14):1471-1504.
8. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg. 2011;1:35-40.
9. Bulte JW, Kraitchman DL. Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol. 2004;5(6):567-584.
10. Daldrup-Link HE, Rudelius M, Piontek G, et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology. 2005;234(1):197-205.
11. Xu H, Aguilar ZP, Yang L, et al. Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. Biomaterials. 2011;32(36):9758-9765.
12. Moroz P, Jones SK, Gray BN. The effect of tumour size on ferromagnetic embolization hyperthermia in a rabbit liver tumour model. Int J Hyperthermia. 2002;18(2):129-140.
13. Frimpong RA, Hilt JZ. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. Nanomedicine (Lond). 2010;5(9):1401-1414.
14. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63(1-2):24-46.
15. McBain SC, Yiu HH, Dobson J. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine. 2008;3(2):169-180.
16. Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005;2(3):194-205.
17. Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl. 2007;46(8):1222-1244.
18. Tallury P, Payton K, Santra S. Silica-based multimodal/multifunctional nanoparticles for bioimaging and biosensing applications. Nanomedicine (Lond). 2008;3(4):579-592.
19. Clarke ED, Simmons J, Folz D, editors. Ceramic Transactions. Westerville, OH: American Ceramic Society; 1999:101.
20. Mohanraj VJ, Barnes TJ, Prestidge CA. Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins. Int J Pharm. 2010;392(1-2):285-293.
21. Zhang C, Wangler B, Morgenstern B, et al. Silica-and alkoxysilanecoated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. Langmuir. 2007;23(3):1427-1434.
22. 4seeds. Nanoscale. 2011;3(2):701-705.
23. Kang K, Choi J, Nam JH, et al. Preparation and characterization of chemically functionalized silica-coated magnetic nanoparticles as a DNA separator. J Phys Chem B. 2009;113(2):536-543.
24. Li YS, Church JS, Woodhead AL, Moussa F. Preparation and characterization of silica coated iron oxide magnetic nano-particles. Spectrochim Acta A Mol Biomol Spectrosc. 2010;76(5):484-489.
25. He X, Duan J, Wang K, Tan W, Lin X, He C. A novel fluorescent label based on organic dye-doped silica nanoparticles for HepG liver cancer cell recognition. J Nanosci Nanotechnol. 2004;4(6):585-589.
26. Poovarodom S, Bass JD, Hwang SJ, Katz A. Investigation of the core-shell interface in gold@silica nanoparticles: a silica imprinting approach. Langmuir. 2005;21(26):12348-12356.
27. Zhang F, Sautter K, Larsen AM, et al. Chemical vapor deposition of three aminosilanes on silicon dioxide: surface characterization, stability, effects of silane concentration, and cyanine dye adsorption. Langmuir. 2010;26(18):14648-14654.
28. Sapsford KE, Ligler FS. Real-time analysis of protein adsorption to a variety of thin films. Biosens Bioelectron. 2004;19(9):1045-1055.
29. Wang HH, Wang YX, Leung KC, et al. Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. Chem Eur J. 2009;15(45):12417-12425.
30. Can K, Ozmen M, Ersoz M. Immobilization of albumin on aminosilane modified superparamagnetic magnetite nanoparticles and its characterization. Colloids Surf B Biointerfaces. 2009;71(1):154-159.
31. Ma YJ, Gu HC. Study on the endocytosis and the internalization mechanism of aminosilane-coated Fe3O4 nanoparticles in vitro. J Mater Sci Mater Med. 2007;18(11):2145-2149.
32. Meyre ME, Clerac R, Mornet S, et al. Multilamellar liposomes entrapping aminosilane-modif ied maghemite nanoparticles: "magnetonions". Phys Chem Chem Phys. 2010;12(39):12794-12801.
33. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn. 1981;17(2):1247-1248.
34. Kumar S, Wan C, Ramaswamy G, Clemens TL, Ponnazhagan S. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther. 2010;18(5):1026-1034.
35. Reddy AM, Kwak BK, Shim HJ, et al. In vivo tracking of mesenchymal stem cells labeled with a novel chitosan-coated superparamagnetic iron oxide nanoparticles using 3.0T MRI. J Korean Med Sci. 2010;25(2):211-219.
36. Krejci J, Pachernik J, Hampl A, Dvorak P. In vitro labelling of mouse embryonic stem cells with SPIO nanoparticles. Gen Physiol Biophys. 2008;27(3):164-173.
37. Gupta AK, Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials. 2005;26(13):1565-1573.
38. Koppolu B, Rahimi M, Nattama S, Wadajkar A, Nguyen KT. Development of multiple-layer polymeric particles for targeted and controlled drug delivery. Nanomedicine. 2010;6(2):355-361.
39. Wang YX, Leung KC, Cheung WH, et al. Low-intensity pulsed ultrasound increases cellular uptake of superparamagnetic iron oxide nanomaterial: results from human osteosarcoma cell line U2OS. J Magn Reson Imaging. 2010;31(6):1508-1513.
40. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89(2): 271-277.
41. Du L, Chen J, Qi Y, et al. Preparation and biomedical application of a non-polymer coated superparamagnetic nanoparticle. Int J Nanomedicine. 2007;2(4):805-812.
42. Wang X, Wang P, Dong Z, et al. Highly sensitive fluorescence probe based on functional SBA-15 for selective detection of Hg. Nanoscale Res Lett. 2010;5(9):1468-1473.
43. Berry CC, Curtis ASG. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys. 2003; 36:R198-R206.
44. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U, Jander S. In vivo MRI of brain inflammation in human ischaemic stroke. Brain. 2004;127(Pt 7):1670-1677.
45. Dousset V, Brochet B, Deloire MS, et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol. 2006;27(5):1000-1005.
46. Neuwelt EA, Varallyay P, Bago AG, Muldoon LL, Nesbit G, Nixon R. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol. 2004;30(5):456-471.
47. Trivedi RA, U-King-Im JM, Graves MJ, et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke. 2004;35(7):1631-1635.
48. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol. 2004;14(10):1851-1858.
49. Tanaka T, Sakai R, Kobayashi R, Hatakeyama K, Matsunaga T. Contributions of phosphate to DNA adsorption/desorption behaviors on aminosilane-modified magnetic nanoparticles. Langmuir. 2009;25(5): 2956-2961.
50. Thorek DL, Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials. 2008;29(26):3583-3590.
51. Kunzmann A, Andersson B, Vogt C, et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol. 2011;253(2):81-93.